A new publication led by UHERO’s Tim Halliday and Ruben Juarez describes how the federal government’s response to the COVID-19 pandemic created a perfect storm in which private laboratories can earn huge profits from PCR testing while potentially impacting health care premium costs.
Halliday, T., Tan, C., Juarez, R. et al. Financial Implications of COVID-19 Polymerase Chain Reaction Tests on Independent Laboratories. Journal of General Internal Medicine (2022). https://doi.org/10.1007/s11606-022-07676-1
